The Precision Medicine and Biomarkers Leaders Summit will provide a forum to network, learn and engage with senior representatives of
leading pharmaceutical and biotech companies worldwide.
More intimate roundtable discussions will also provide an opportunity for you and your peers to cover, in detail, issues such as fulfilling the potential of big data, conducting precision medicine clinical trials and advancing liquid biopsies to the clinic.
The 7th InterAmerican Oncology Conference "Current Status and Future of Anti-Cancer Targeted Therapies" will be held in Buenos Aires, Argentina in October 5th and 6th, 2017.
An outstanding faculty of speakers from the United States and Europe has committed in this meeting.
The conference agenda will focus on new translational advances in the treatment of cancer as well as provide updates of conventional therapies for a number of the most common tumor types. The meeting objectives are designed to introduce the audience to the latest information on targeted therapies, immunotherapies and emerging treatments in early development.
Oxford Global Conferences are proud to present the 2nd Annual Biomarkers & Precision Medicine USA Congress co-located with our 4th Annual Drug Discovery USA Congress, taking place on the 09-10 October 2017 in San Diego, USA.
Over 250 delegates representing leading biotech companies, global pharma organisations and internationally renowned academic institutions.
Over 40 presentations, case studies and panel discussions focused on the key issues in biomarker research, companion diagnostics, personalised medicine and clinical biomarkers.
5 Interactive Streams:
14 pre-scheduled one to one meetings, exhibition and informal networking opportunities. This event is co-located with our 4th Annual Drug Discovery USA Congress.
Translational Biomarkers and Companion Diagnostics Development Consortium
22nd June 2017, 9 am. PST, 12 noon EST, 5 pm. BST
Click here to register today, for free.
Scientific and Regulatory Considerations for the Analytical Validation of Assays for the Qualification of Biomarkers
8th August 2017, 9 am. PST, 12 noon EST, 5 pm. BST
Click here to register today, for free.
Can’t make the dates? Still register and a copy of the webinar recording will be sent to you.For further information, click here: http://bit.ly/22r99ki
Oxford Global are proud to announce the return of the NGS & Clinical Diagnostics Asia Congress. Taking place on 10-11 October 2017 at the Concorde Hotel Singapore, this event will attract 300+ delegates, representing leading sequencing centres, global pharmaceutical organisations and world-renowned research institutions.
Over 35+ presentations and case studies focused on the key developments in sequencing, analysis and bioinformatics, clinical and therapeutic applications and ‘omics case studies, will be discussed across the two days.
The two streams will focus on:
• NGS Technologies and Key Therapeutic Applications
• Clinical Applications of NGS – Based Genomic Profiling and Molecular Diagnostics
Download the full congress agenda here: https://www.ngsasia-congress.com/download-agenda-2/
Alternatively, contact Danielle Dalby: firstname.lastname@example.org
The 9th World Congress of Melanoma and the 14th International Congress of the Society for Melanoma Research will be held from 18th to 21st October 2017 in Brisbane, Australia. The joint meeting will bring together the world’s leading melanoma researchers and clinicians to showcase the latest developments in melanoma diagnosis, treatment and research.
This global summit will accelerate scientific and clinical investigations into melanoma, providing an opportunity for delegates from multi-disciplinary fields to meet in a warm climate to exchange knowledge and expertise.
We plan to inspire new partnerships and innovations, and will offer a range of significant benefits to international delegates from across the world, including opportunities to explore new professional horizons that pivot from a uniquely global focus on melanoma and skin cancer control.
The NCRI Cancer Conference is the largest annual cancer research meeting in the UK, attracting over 1,500 participants from across the spectrum of basic, translational and clinical research. We are committed to share and make available to all attendees the best cancer research from all over the world and encourage cross-pollination. The Conference provides a high profile platform where key stakeholders of cancer research come together to discuss, present and showcase high-quality research. The programme covers six main themes - Diagnosis and therapy, Epidemiology and prevention, Health services research, Information, patients and the public, Survivorship and end of life care and the cancer cell and model systems – which are organised in sessions across 4 days. The Conference programme includes plenty of networking opportunities, allowing participants to make the most of their time in Liverpool.
Abstract submission: 3 April – 4 June
Earlybird registration: 3 April – 30 June
Standard registration: 1 July – 22 October
Late breaking abstract submission: 31 July – 28 August
Oxford Global are pleased to announce the return of Europe’s largest Genomics Congress: the 9th Annual NGS & Clinical Diagnostics Congress.
Join 600+ end users representing internationally renowned research & academic institutions, clinical research institutions, healthcare organisations as well as leading pharmaceutical and biotech companies
Hear 90+ case studies and presentations focused on the developments in NGS technologies, NGS data analysis as well as clinical applications & diagnostics of NGS.
New to 2017!
Learn more about NGS in pharma: biomarker development, precision medicine and clinical diagnostics. Case studies at this genomics conference include: linking NGS to clinical trials, biomarkers for precision therapies and innovative biology.
NGS, genomics and clinical diagnostics in healthcare: at this genomics conference, discuss the latest microbiome research results, updates in the clinical applications of NGS in healthcare and clinical metagenomics updates.
Download the full congress agenda here: https://www.nextgenerationsequencing-congress.com/download-agenda/